|
David RooklinOffice: 1016 Silver Building, 100 Washington Square East |
BackgroundDavid Rooklin is currently a PhD student in the Computational Biology Program (COB) and Chemistry Department at New York University. During his first semester at NYU, he worked on the computer simulation of in vitro selection, a technique used to isolate functional RNA aptamers from large random pools. He has worked in the laboratory of Josef Michl at the University of Colorado in Boulder, where he focused on theoretical chemistry research and contributed to two published papers: one on the TD-DFT treatment of electronic excitations in permethyloligosilanes and one on delocalized sigma bonds in oligosilanes. Prior to this, he received his B.A. in Biochemistry from Oberlin College. Present ResearchCurrently, David is working with the Yingkai Zhang group in the NYU Chemistry Department. He is undertaking a computational study of the regulation mechanisms of Protein Tyrosine Phosphatase 1B (PTP1B), an important drug target for Diabetes Type 2 therapy. |
|